Log In
Print this Print this

Lucentis, ranibizumab (RG3645)

Also known as: formerly rhuFab V2

  Manage Alerts
Collapse Summary General Information
Company Genentech Inc.
DescriptionHumanized mAb fragment against VEGF-A
Molecular Target Vascular endothelial growth factor A (VEGF-A)
Mechanism of ActionVascular endothelial growth factor A (VEGF-A) inhibitor; Antibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
Get a free BioCentury trial today